Literature DB >> 20140806

Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts.

Katarzyna Winnicka1, Krzysztof Bielawski, Anna Bielawska, Wojciech Miltyk.   

Abstract

In this study, we looked at the effect of ouabain, digoxin and proscillaridin A on human fibroblasts. These data show that low concentrations of ouabain, digoxin and proscillaridin A can activate proliferation of human fibroblasts, suggesting that the Na+, K+-adenosine triphosphatase complex may act as a transducing receptor. It was shown that 30 nM ouabain, digoxin and proscillaridin A stimulated an antiapoptotic action by the increase in the level of phosphorylated extracellular signal-regulated kinases (P-ERK 1/2). Ouabain, digoxin and proscillaridin A only at the relatively high concentration of 300 nM increased intracellular Ca2+ concentration, activated caspase-3 and induced apoptosis in human fibroblasts. In terms of reduction in cell viability, antiproliferative and apoptotic activity, these cardiac glycosides rank in the order proscillaridin A >digoxin >ouabain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140806     DOI: 10.1080/14786410902991878

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  18 in total

1.  Depolarization of Cellular Resting Membrane Potential Promotes Neonatal Cardiomyocyte Proliferation In Vitro.

Authors:  Jen-Yu Lan; Corin Williams; Michael Levin; Lauren Deems Black
Journal:  Cell Mol Bioeng       Date:  2014-09-01       Impact factor: 2.321

2.  A Rare Case of Digoxin Associated Gingival Overgrowth.

Authors:  Sanjeela Rakshith Guru; Aparnna Suresh; Shyam Padmanabhan; Adithya Reddy
Journal:  J Clin Diagn Res       Date:  2017-04-01

3.  "The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?

Authors:  Heidrun Weidemann
Journal:  J Carcinog       Date:  2012-02-17

4.  Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.

Authors:  Emilie Denicolaï; Nathalie Baeza-Kallee; Aurélie Tchoghandjian; Manon Carré; Carole Colin; Carine Jiguet Jiglaire; Sandy Mercurio; Christophe Beclin; Dominique Figarella-Branger
Journal:  Oncotarget       Date:  2014-11-15

5.  21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions.

Authors:  Sayonarah C Rocha; Marco T C Pessoa; Luiza D R Neves; Silmara L G Alves; Luciana M Silva; Herica L Santos; Soraya M F Oliveira; Alex G Taranto; Moacyr Comar; Isabella V Gomes; Fabio V Santos; Natasha Paixão; Luis E M Quintas; François Noël; Antonio F Pereira; Ana C S C Tessis; Natalia L S Gomes; Otacilio C Moreira; Ruth Rincon-Heredia; Fernando P Varotti; Gustavo Blanco; Jose A F P Villar; Rubén G Contreras; Leandro A Barbosa
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 6.  "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols.

Authors:  Anna Bogdanova; Irina Y Petrushanko; Pablo Hernansanz-Agustín; Antonio Martínez-Ruiz
Journal:  Front Physiol       Date:  2016-08-02       Impact factor: 4.566

Review 7.  Na+/K+-ATPase Revisited: On Its Mechanism of Action, Role in Cancer, and Activity Modulation.

Authors:  Jiří Bejček; Vojtěch Spiwok; Eva Kmoníčková; Silvie Rimpelová
Journal:  Molecules       Date:  2021-03-28       Impact factor: 4.411

8.  Digitoxin and its analogs as novel cancer therapeutics.

Authors:  Hosam A Elbaz; Todd A Stueckle; William Tse; Yon Rojanasakul; Cerasela Zoica Dinu
Journal:  Exp Hematol Oncol       Date:  2012-04-05

9.  Human breast tumor cells are more resistant to cardiac glycoside toxicity than non-tumorigenic breast cells.

Authors:  Rebecca J Clifford; Jack H Kaplan
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  Ouabain Enhances ADPKD Cell Apoptosis via the Intrinsic Pathway.

Authors:  Jessica Venugopal; Gustavo Blanco
Journal:  Front Physiol       Date:  2016-03-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.